Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.
Emily L HoskinsEric SamorodnitskyMichele R WingJulie A Wallace ReeserJulia F HopkinsKarthikeyan MurugesanZheng KuangRaven VellaLeah SteinZachary RischLianbo YuSerifat O AdebolaAnoosha ParuchuriJohn CarptenJad ChahoudStephen B EdgeJill M KolesarMartin McCarterKenneth G NeppleMatthew J ReilleyCourtney ScaifeAbhishek TripathiNancy SingleRichard S P HuangLee A AlbackerSameek RoychowdhuryPublished in: JCO precision oncology (2023)
SVs in cancer and lend support for prospective clinical trials to target these alterations.